Imatinib plasma monitoring-guided dose modification for managing imatinib-related toxicities in gastrointestinal stromal tumor patients.

We present two cases of advanced GIST patients in whom we managed imatinib-related toxicities through dose modifications guided by imatinib plasma level monitoring. Imatinib blood level testing may be a promising approach for fine-tuning imatinib dosage for better tolerability and optimal clinical outcomes in patients with advanced GIST.
PMID: 23960456 [PubMed - in process]

Source: J Korean Med Sci - August 1, 2013 Category: Journals (General) Authors: Yoon S, Ryu MH, Yoo C, Beck MY, Ryoo BY, Kang YK Tags: J Korean Med Sci Source Type: research